University of Colorado Anschutz Medical Campus
Introduction
University Of Colorado Anschutz Medical Campus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-institution"> [@anschutz]
Overview
flowchart TD
CU["CU Anschutz"]
RESEARCH["Research"]
EDUCATION["Education"]
CU -->|"advances"| RESEARCH
CU -->|"provides"| EDUCATION
style CU fill:#4fc3f7,stroke:#333,color:#000
style RESEARCH fill:#81c784,stroke:#333,color:#000
style EDUCATION fill:#81c784,stroke:#333,color:#000
The University of Colorado Anschutz Medical Campus (CU Anschutz) is a premier academic medical center located in Aurora, Colorado. As the largest academic health center in the Rocky Mountain region, CU Anschutz brings together world-class research, education, and clinical care in a collaborative environment. [@potter2024]
The campus houses the University of Colorado School of Medicine, the University of Colorado School of Dental Medicine, the Colorado School of Public Health, and the University of Colorado Cancer Center. The neuroscience research programs are particularly strong, with major focus areas in: [@deane2023]
...University of Colorado Anschutz Medical Campus
Introduction
University Of Colorado Anschutz Medical Campus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-institution"> [@anschutz]
Overview
Mermaid diagram (expand to render)
The University of Colorado Anschutz Medical Campus (CU Anschutz) is a premier academic medical center located in Aurora, Colorado. As the largest academic health center in the Rocky Mountain region, CU Anschutz brings together world-class research, education, and clinical care in a collaborative environment. [@potter2024]
The campus houses the University of Colorado School of Medicine, the University of Colorado School of Dental Medicine, the Colorado School of Public Health, and the University of Colorado Cancer Center. The neuroscience research programs are particularly strong, with major focus areas in: [@deane2023]
- Alzheimer's Disease Research: The University of Colorado Alzheimer's and Cognition Center conducts translational research on biomarkers, early detection, and novel therapeutics
- Parkinson's Disease: Movement disorders program with expertise in deep brain stimulation and experimental therapeutics
- Neurobiology of Aging: Studies on cognitive decline, mechanisms of neurodegeneration, and lifestyle interventions
- Neuroinflammation: Research on microglial biology and neuroimmune mechanisms in neurodegenerative disease
Key research facilities include the Center for Neuroscience and Behavioral Medicine, the Gates Center for Regenerative Medicine, and the Ludeman Family Center for Women's Health Research.
<h3 class="infobox-title">University of Colorado Anschutz Medical Campus</h3>
<table class="infobox-table">
<tr><th>Location</th><td>Aurora, Colorado, USA</td></tr>
<tr><th>Type</th><td>Academic Medical Center</td></tr>
<tr><th>Founded</th><td>2011</td></tr>
<tr><th>Website</th><td><a href="https://www.cuanschutz.edu/" target="_blank">University of Colorado Anschutz Medical Campus</a></td></tr>
</table>
</div>
The University of Colorado Anschutz Medical Campus is one of the nation's premier academic health centers, located in Aurora, Colorado. The campus houses the University of Colorado School of Medicine, the CU College of Nursing, the Skaggs School of Pharmacy and Pharmaceutical Sciences, and the Colorado School of Public Health. CU Anschutz is a leader in neurodegenerative disease research, particularly in Alzheimer's disease, Parkinson's disease, and ALS.
History
The CU Anschutz Medical Campus was established in 2011 when the University of Colorado Anschutz Medical Campus was formed by merging the University of Colorado Health Sciences Center with the Fitzsimons Life Science Center. The campus sits on the former Fitzsimons Army Medical Center, which was converted to a civilian academic health complex after the base closure in the 1990s. Today, it is one of the largest academic health centers in the Rocky Mountain region.
Campus and Facilities
The 227-acre campus features state-of-the-art research and clinical facilities:
- Charles C. Gates Center for Regenerative Medicine — stem cell research and therapeutic development
- Rocky Mountain Alzheimer's Disease Center — clinical care and research coordination
- Barbara Davis Center for Childhood Diabetes — metabolic links to neurodegeneration research
- Fitzsimons Building — main research laboratories
- Children's Hospital Colorado — pediatric neuroscience research
Research facilities include advanced imaging suites (MRI, PET, CT), mass spectrometry core facilities, flow cytometry, confocal microscopy, and animal research facilities.
Neuroscience and Neurodegeneration Research
The campus hosts several major research programs focused on neurodegeneration:
- Alzheimer's Disease Research Center: One of 33 NIH-funded Alzheimer's Disease Research Centers, conducting clinical trials and longitudinal studies on aging and cognitive decline. Focus areas include biomarker development, early detection, and novel therapeutic approaches.
- Parkinson's Disease Research: Multiple labs investigating dopaminergic neuron degeneration, [alpha-synuclein](/proteins/alpha-synuclein) pathology, LRRK2 mutations, and novel therapeutic approaches including gene therapy and cell replacement.
- ALS and Motor [Neuron](/entities/neurons) Disease: Research programs focusing on [TDP-43](/proteins/tdp-43) proteinopathy, SOD1 mutations, [C9orf72](/entities/c9orf72) repeat expansions, and RNA metabolism in motor neuron disease.
Key Research Areas
Neuroinflammation: Studies on microglial activation, cytokine signaling, [complement system](/entities/complement-system) activation, and the role of chronic neuroinflammation in disease progression.
Protein Aggregation: Research on [amyloid-beta](/proteins/amyloid-beta), [tau](/proteins/tau), [alpha-synuclein](/proteins/alpha-synuclein), and [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregation mechanisms, strain classification, and propagation.
Neurovascular Function: Investigation of [blood-brain barrier](/entities/blood-brain-barrier) dysfunction, cerebral blood flow alterations, and vascular contributions to cognitive impairment.
Stem Cell and Regenerative Medicine: iPSC-derived neuron models, therapeutic screening platforms, and regenerative approaches using stem cell transplantation.
Metabolism and Neurodegeneration: Studies on the intersection of metabolic disease (diabetes, obesity) and neurodegenerative disorders.Notable Programs
- Mountain West ALS Center: Comprehensive care and research for patients with ALS and related motor neuron diseases
- Lewy Body Dementia Program: Diagnosis and research on DLB and PDD
- Frontotemporal Dementia Clinic: Specialized care and research for FTD spectrum disorders
Key Researchers
| Researcher | Focus Area |
|------------|------------|
| Huntington Potter | Alzheimer's disease, immunotherapy, [ApoE](/proteins/apoe-protein) |
| Kevin Deane | Alzheimer's disease, neuroinflammation, [microglia](/entities/microglia) |
| Catherine Gallagher | Parkinson's disease, alpha-synuclein |
| Brianne Betts | ALS, TDP-43, RNA metabolism |
| David B. Miller | Neurodegeneration, protein aggregation |
Notable Contributions
- Pioneering work on Alzheimer's disease immunotherapy and antibody therapeutics
- Development of novel biomarkers for early detection of neurodegeneration
- Research on the role of [ApoE](/proteins/apoe-protein) in Alzheimer's disease pathogenesis
- Studies on neuroinflammation as a driver of disease progression
- Clinical trials for novel disease-modifying therapies in AD and PD
- Stem cell approaches to treating neurodegenerative disorders
Disease Focus
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Lewy Body Dementia](/diseases/lewy-body-dementia)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- Amyotrophic Lateral Sclerosis (ALS)
- [Multiple System Atrophy](/diseases/multiple-system-atrophy)
- Vascular Cognitive Impairment
Training Programs
CU Anschutz offers comprehensive training opportunities:
- Neurology residency program
- Movement disorders fellowship
- Neurodegeneration research fellowship
- Neuroscience graduate program
- Postdoctoral training positions
- Medical student research rotations
Collaborations
The campus collaborates extensively with:
- NIH National Institute on Aging (NIA)
- NIH National Institute of Neurological Disorders and Stroke (NINDS)
- Michael J. Fox Foundation for Parkinson's Research
- Alzheimer's Association
- ALS Association
- Other academic medical centers in the Mountain West region
Background
The study of University Of Colorado Anschutz Medical Campus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Institutions Index](/institutions)
- [United States Neuroscience Research](/institutions?region=usa)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
- [CU Anschutz Homepage](https://www.cuanschutz.edu/)
- [School of Medicine](https://medschool.cuanschutz.edu/)
- [Alzheimer's Disease Research Center](https://www.cuanschutz.edu/centers/alzheimers)
- [Parkinson's Disease Research](https://www.cuanschutz.edu/centers/parkinsons)
- [PubMed - CU Anschutz](https://pubmed.ncbi.nlm.nih.gov/?term=CU+Anschutz+Alzheimer)
References
Unknown, University of Colorado Anschutz Medical Campus. Official website (n.d.)
Unknown, CU Anschutz Alzheimer's Disease Research Center. Research programs and clinical trials (n.d.)
Potter H, et al, Alzheimer disease research: progress and future directions (2024)
Deane K, et al, Neuroinflammation in Alzheimer's disease (2023)